IL-23 in infections, inflammation, autoimmunity and cancer: Possible role in HIV-1 and AIDS

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 1, 2012, Pages 95-112

  Yannam, Govardhana Rao ^a   Gutti, Tanuja ^a   Poluektova, Larisa Y ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Autoimmune disorders; Bacterial infection; Central nervous system; HIV 1; IL 23; Interleukin 17

Indexed keywords

BETA GLUCAN; CD40 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; LIPOPOLYSACCHARIDE; PATTERN RECOGNITION RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; CANDIDA ALBICANS; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CYTOKINE RELEASE; ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFLAMMATION; MUCOSAL IMMUNITY; MULTIPLE SCLEROSIS; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TOXOPLASMA GONDII; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; COMMUNICABLE DISEASES; HIV-1; HUMANS; INFLAMMATION; INTERLEUKIN-23; NEOPLASMS;

EID: 84860703085     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-011-9315-2     Document Type: Review

References (198)

1. Agarwal SK, Gourh P, Shete S, Paz G, Divecha D, Reveille JD, Assassi S, Tan FK, Mayes MD, Arnett FC (2009) Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis. J Rheumatol 36:2715-2723
2. Agrawal S, Gupta S, Agrawal A (2010) Human dendritic cells activated via dectin-1 are efficient at priming Th17, cytotoxic CD8 T and B cell responses. PLoS ONE 5:e13418
3. Ahern PP, Izcue A, Maloy KJ, Powrie F (2008) The interleukin-23 axis in intestinal inflammation. Immunol Rev 226:147-159
4. Alfano M, Crotti A, Vicenzi E, Poli G (2008) New players in cytokine control of HIV infection. Curr HIV/AIDS Rep 5:27-32 (Pubitemid 351480778)
5. Aloisi F, Pujol-Borrell R (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6:205-217 (Pubitemid 43290990)
6. Al-Salleeh F, Petro TM (2007) TLR3 and TLR7 are involved in expression of IL-23 subunits while TLR3 but not TLR7 is involved in expression of IFN-beta by Theiler's virus-infected RAW264.7 cells. Microb nfect 9:1384-1392 (Pubitemid 47539212)
7. Al-Salleeh F, Petro TM (2008) Promoter analysis reveals critical roles for SMAD-3 and ATF-2 in expression of IL-23 p19 in macrophages. J Immunol 181:4523-4533
8. Ancuta P, Monteiro P, Sekaly RP (2010) Th17 lineage commitment and HIV-1 pathogenesis. Curr Opin HIV AIDS 5:158-165
9. Andersson J, Boasso A, Nilsson J, Zhang R, Shire NJ, Lindback S, Shearer GM, Chougnet CA (2005) The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIVinfected patients. J Immunol 174:3143-3147 (Pubitemid 40354012)
10. Antinori A et al (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799 (Pubitemid 350059308)
11. Ashtekar AR, Zhang P, Katz J, Deivanayagam CC, Rallabhandi P, Vogel SN, Michalek SM (2008) TLR4-mediated activation of dendritic cells by the heat shock protein DnaK from Francisella tularensis. J Leukoc Biol 84:1434-1446 (Pubitemid 352774478)
12. Ban Y, Tozaki T, Taniyama M, Nakano Y, Yoneyama K, Hirano T (2009) Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity 42:126-130
13. Begum NA, Ishii K, Kurita-Taniguchi M, Tanabe M, Kobayashi M, Moriwaki Y, Matsumoto M, Fukumori Y, Azuma I, Toyoshima K, Seya T (2004) Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages. Infect Immun 72:937-948 (Pubitemid 38166674)
14. Bhan U, Ballinger MN, Zeng X, Newstead MJ, Cornicelli MD, Standiford TJ (2010) Cooperative interactions between TLR4 and TLR9 regulate interleukin 23 and 17 production in a murine model of gram negative bacterial pneumonia. PLoS ONE 5: e9896
15. Bissel SJ, Wang G, Bonneh-Barkay D, Starkey A, Trichel AM, Murphey-Corb M, Wiley CA (2008) Systemic and brain macrophage infections in relation to the development of simian immunodeficiency virus encephalitis. J Virol 82:5031-5042 (Pubitemid 351657063)
16. Bohlius J, Schmidlin K, Costagliola D, Fatkenheuer G, May M, Caro-Murillo AM, Mocroft A, Bonnet F, Clifford G, Karafoulidou A, Miro JM, Lundgren J, Chene G, Egger M (2009) Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antivir Ther 14:1065-1074
17. Broberg EK, Setälä N, Erälinna JP, Salmi AA, Röyttä M, Hukkanen V (2002) Herpes simplex virus type 1 infection induces upregulation of interleukin-23 (p19) mRNA expression in trigeminal ganglia of BALB/c mice. J Interferon Cytokine Res 22:641-651 (Pubitemid 35034522)
18. Broberg EK, Peltoniemi J, Nygardas M, Vahlberg T, Roytta M, Hukkanen V (2004) Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice. J Virol 78:13139-13152 (Pubitemid 39507821)
19. Budka H (1990) Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS). Acta Neuropathol 79:611-619 (Pubitemid 20170337)
20. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F (2010) Innate lymphoid cells drive interleukin-23- dependent innate intestinal pathology. Nature 464:1371-1375
21. Butchar JP, Rajaram MV, Ganesan LP, Parsa KV, Clay CD, Schlesinger LS, Tridandapani S (2007) Francisella tularensis induces IL-23 production in human monocytes. J Immunol 178:4445-4454 (Pubitemid 46492396)
22. Cecchinato V, Tryniszewska E, Ma ZM, Vaccari M, Boasso A, Tsai WP, Petrovas C, Fuchs D, Heraud JM, Venzon D, Shearer GM, Koup RA, Lowy I, Miller CJ, Franchini G (2008) Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol 180:5439-5447
23. Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Blumenschein W, Churakovsa T, Low J, Presta L, Hunter CA, Kastelein RA, Cua DJ (2006) Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Investig 116:1317-1326
24. Cho JS, Pietras EM, Garcia NC, Ramos RI, Farzam DM, Monroe HR, Magorien JE, Blauvelt A, Kolls JK, Cheung AL, Cheng G, Modlin RL, Miller LS (2010) IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Investig 120:1762-1773
25. Cianfrocca M, Roenn JH (1998) Epidemic Kaposi's sarcoma. Oncology (Williston Park) 12:1375-1381, 1385; discussion 1385-1390
26. Ciric B, El-behi M, Cabrera R, Zhang GX, Rostami A (2009) IL-23 drives pathogenic IL-17-producing CD8+ T cells. J Immunol 182:5296-5305
27. Clements JE, Babas T, Mankowski JL, Suryanarayana K, Piatak M Jr, Tarwater PM, Lifson JD, Zink MC (2002) The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 186:905-913
28. Cocco C, Canale S, Frasson C, Di Carlo E, Ognio E, Ribatti D, Prigione I, Basso G, Airoldi I (2010) Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. Blood 116:3887-3898
29. Codarri L, Fontana A, Becher B (2010) Cytokine networks in multiple sclerosis: lost in translation. Curr Opin Neurol 23:205-211
30. Constantinescu CS, Tani M, Ransohoff RM, Wysocka M, Hilliard B, Fujioka T, Murphy S, Tighe PJ, Sarma JD, Trinchieri G, Rostami A (2005) Astrocytes as antigen-presenting cells: expression of IL-12/IL-23. J Neurochem 95:331-340 (Pubitemid 41457502)
31. Cooper AM, Khader SA (2008) The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 226:191-204
32. Cooper AM, Kipnis A, Turner J, Magram J, Ferrante J, Orme IM (2002) Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol 168:1322-1327 (Pubitemid 34094502)
33. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867 (Pubitemid 36019639)
34. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744-748 (Pubitemid 36227625)
35. De Nitto D, Sarra M, Cupi ML, Pallone F, Monteleone G (2010) Targeting IL-23 and Th17-cytokines in inflammatory bowel diseases. Curr Pharm Des 16:3656-3660
36. De Vuyst H, Lillo F, Broutet N, Smith JS (2008) HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Canc Prev 17:545-554
37. Desvignes L, Ernst JD (2009) Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31:974-985
38. Dietlin TA, Cua DJ, Burke KA, Lund BT, van der Veen RC (2009) Role of IL-23 in mobilization of immunoregulatory nitric oxideor superoxide-producing Gr-1+ cells from bone marrow. Free Radic Biol Med 47:357-363
39. Dillon SM, Rogers LM, Howe R, Hostetler LA, Buhrman J, McCarter MD, Wilson CC (2010) Human intestinal lamina propria CD1c+ dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7/8 stimulation. J Immunol 184:6612-6621
40. Dong C (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8:337-348 (Pubitemid 351595217)
41. Douek D (2007) HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med 15:114-117
42. Dower K, Ellis DK, Saraf K, Jelinsky SA, Lin LL (2008) Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. J Immunol 180:3520-3534
43. Duerr RH et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461-1463 (Pubitemid 44871953)
44. Dunham RM, Cervasi B, Brenchley JM, Albrecht H, Weintrob A, Sumpter B, Engram J, Gordon S, Klatt NR, Frank I, Sodora DL, Douek DC, Paiardini M, Silvestri G (2008) CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. J Immunol 180:5582-5592
45. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137-148 (Pubitemid 39094044)
46. El-Behi M, Ciric B, Dai H, Yan Y, Cullimore M, Safavi F, Zhang GX, Dittel BN, Rostami A (2011) The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 12:568-575
47. Engwerda CR, Murphy ML, Cotterell SE, Smelt SC, Kaye PM (1998) Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur J Immunol 28:669-680 (Pubitemid 28101744)
48. Epple HJ, Loddenkemper C, Kunkel D, Troger H, Maul J, Moos V, Berg E, Ullrich R, Schulzke JD, Stein H, Duchmann R, Zeitz M, Schneider T (2006) Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108:3072-3078
49. Fenoglio D, Poggi A, Catellani S, Battaglia F, Ferrera A, Setti M, Murdaca G, Zocchi MR (2009) Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood 113:6611-6618
50. Ganss R, Arnold B, Hammerling GJ (2004) Mini-review: overcoming tumor-intrinsic resistance to immune effector function. Eur J Immunol 34:2635-2641 (Pubitemid 39430139)
51. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, Presky DH (1998) The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 16:495-521 (Pubitemid 28183374)
52. Gendelman H, Tardieu M (1994) Macrophages/microglia and the pathophysiology of CNS injuries in AIDS. J Leukoc Biol 56:387-388 (Pubitemid 24295811)
53. Ghilardi N, Kljavin N, Chen Q, Lucas S, Gurney AL, De Sauvage FJ (2004) Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J Immunol 172:2827-2833 (Pubitemid 38263667)
54. Gottfried-Blackmore A, Kaunzner UW, Idoyaga J, Felger JC, McEwen BS, Bulloch K (2009) Acute in vivo exposure to interferon-{gamma} enables resident brain dendritic cells to become effective antigen presenting cells. Proc Natl Acad Sci USA 106(49):20918-23
55. Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393-407
56. Griffiths MH, Miller RF, Semple SJ (1995) Interstitial pneumonitis in patients infected with the human immunodeficiency virus. Thorax 50:1141-1146
57. Hannon FB, Easterbrook PJ, Padley S, Boag F, Goodall R, Phillips RH (1998) Bronchopulmonary Kaposi's sarcoma in 106 HIV-1 infected patients. Int J STD AIDS 9:518-525 (Pubitemid 28423482)
58. Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, Quinton LJ, Odden AR, Shellito JE, Bagby GJ, Nelson S, Kolls JK (2005) Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202:761-769 (Pubitemid 41345965)
59. Heaton RK et al (2010) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J NeuroVirol 17:3-16
60. Higgins SC, Jarnicki AG, Lavelle EC, Mills KH (2006) TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol 177:7980-7989 (Pubitemid 44846315)
61. Hong KJ, Wickstrum JR, Yeh HW, Parmely MJ (2007) Toll-like receptor 2 controls the gamma interferon response to Francisella tularensis by mouse liver lymphocytes. Infect Immun 75:5338-5345 (Pubitemid 350033621)
62. Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y (2008) Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 93:1077-1081 (Pubitemid 351398595)
63. Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, McKenzie BS, Powrie F, Maloy KJ (2006) Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203:2473-2483 (Pubitemid 44664617)
64. Hunter CA, Subauste CS, Van Cleave VH, Remington JS (1994) Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun 62:2818-2824 (Pubitemid 24203966)
65. Ichiyama K, Yoshida H, Wakabayashi Y, Chinen T, Saeki K, Nakaya M, Takaesu G, Hori S, Yoshimura A, Kobayashi T (2008) Foxp3 inhibits RORγt-mediated IL-17A mRNA transcription through direct interaction with RORγt. J Biol Chem 283:17003-17008
66. Illes Z, Safrany E, Peterfalvi A, Magyari L, Farago B, Pozsonyi E, Rozsa C, Komoly S, Melegh B (2008) 3'UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis. Neurosci Lett 431:36-38
67. Ingiliz P, Appenrodt B, Gruenhage F, Vogel M, Tschampa H, Tasci S, Rockstroh JK (2006) Lymphoid pneumonitis as an immune reconstitution inflammatory syndrome in a patient with CD4 cell recovery after HAART initiation. HIV Med 7:411-414 (Pubitemid 44123253)
68. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121-1133 (Pubitemid 44380299)
69. Izcue A, Hue S, Buonocore S, Arancibia-Carcamo CV, Ahern PP, Iwakura Y, Maloy KJ, Powrie F (2008) Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28:559-570 (Pubitemid 351467043)
70. Jetten AM (2009) Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 7:e003
71. Jin Y, Lundkvist G, Dons L, Kristensson K, Rottenberg ME (2004) Interferon-gamma mediates neuronal killing of intracellular bacteria. Scand J Immunol 60:437-448 (Pubitemid 39487510)
72. Kader M, Bixler S, Piatak M, Lifson J, Mattapallil JJ (2009) Antiretroviral therapy fails to restore the severe Th-17: Tc-17 imbalance observed in peripheral blood during simian immunodeficiency virus infection. J Med Primatol 38(Suppl 1):32-38
73. Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A (2010) IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol 185:5453-5462
74. Kamada N, Hisamatsu T, Okamoto S, Chinen H, Kobayashi T, Sato T, Sakuraba A, Kitazume MT, Sugita A, Koganei K, Akagawa KS, Hibi T (2008) Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Investig 118:2269-2280 (Pubitemid 351872344)
75. Kasper LH, Everitt D, Leist TP, Ryan KA, Mascelli MA, Johnson K, Raychaudhuri A, Vollmer T (2006) A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis. Curr Med Res Opin 22:1671-1678 (Pubitemid 44449223)
76. Kastelein RA, Hunter CA, Cua DJ (2007) Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 25:221-242 (Pubitemid 46697908)
77. Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21:317-337
78. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13:1173-1175 (Pubitemid 47530640)
79. Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM, Ghilardi N, deSauvage F, Cooper AM (2005) IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL- 12p70 is available. J Immunol 175:788-795 (Pubitemid 41094960)
80. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, Locksley RM, Haynes L, Randall TD, Cooper AM (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8:369-377 (Pubitemid 46745412)
81. Kielian T (2004) Microglia and chemokines in infectious diseases of the nervous system: views and reviews. Front Biosci 9:732-750 (Pubitemid 39043747)
82. Kikly K, Liu L, Na S, Sedgwick JD (2006) The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 18:670-675 (Pubitemid 44635178)
83. Kim B, Sarangi PP, Azkur AK, Kaistha SD, Rouse BT (2008) Enhanced viral immunoinflammatory lesions in mice lacking IL- 23 responses. Microb Infect 10:302-312
84. Kim S, Han S, Withers DR, Gaspal F, Bae J, Baik S, Shin HC, Kim KS, Bekiaris V, Anderson G, Lane P, Kim MY (2011) CD117 CD3 CD56 OX40Lhigh cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues. Eur J Immunol 41:1563-1572
85. Kinter A, McNally J, Riggin L, Jackson R, Roby G, Fauci AS (2007) Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory Tcells fromHIV-infected individuals. Proc Natl Acad Sci USA 104:3390-3395 (Pubitemid 46364169)
86. Klatt NR, Brenchley JM (2010) Th17 cell dynamics in HIV infection. Curr Opin HIV AIDS 5:135-140
87. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467-476 (Pubitemid 39370503)
88. Kotler DP, Reka S, Clayton F (1993) Intestinal mucosal inflammation associated with human immunodeficiency virus infection. Dig Dis Sci 38:1119-1127 (Pubitemid 23175136)
89. Kramer-Hammerle S, Rothenaigner I,Wolff H, Bell JE, Brack-Werner R (2005) Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 111:194-213 (Pubitemid 40909736)
90. Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M, Udalova IA (2011) IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 12:231-238
91. Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W (2007) Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 178:6730-6733 (Pubitemid 46847396)
92. Kurzeja M, Rudnicka L, Olszewska M (2011) New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab. Am J Clin Dermatol 12:113-125
93. Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, Basham B, McClanahan T, Kastelein RA, Oft M (2006) IL-23 promotes tumour incidence and growth. Nature 442:461-465 (Pubitemid 44264796)
94. Langrish CL, McKenzie BS, Wilson NJ, De Waal MR, Kastelein RA, Cua DJ (2004) IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 202:96-105 (Pubitemid 39576907)
95. Lankford CS, Frucht DM (2003) A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 73:49-56 (Pubitemid 36125674)
96. Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, Dhodapkar M, Krueger JG (2004a) Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199:125-130 (Pubitemid 38076484)
97. Lee S, French MA, Price P (2004b) IL-23 and IFN-gamma deficiency in immunodeficient HIV patients who achieved a long-term increase in CD4 T-cell counts on highly active antiretroviral therapy. AIDS 18:1337-1340 (Pubitemid 38822714)
98. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, Tybulewicz V, Brown GD, Ruland J, Reis e Sousa C (2007) Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8:630-638 (Pubitemid 46785127)
99. Li J, Gran B, Zhang GX, Ventura ES, Siglienti I, Rostami A, Kamoun M (2003) Differential expression and regulation of IL-23 and IL- 12 subunits and receptors in adult mouse microglia. J Neurol Sci 215:95-103 (Pubitemid 37272203)
100. Li JC, Yim HC, Lau AS (2010) Role of HIV-1 Tat in AIDS pathogenesis: its effects on cytokine dysregulation and contributions to the pathogenesis of opportunistic infection. AIDS 24:1609-1623
101. Li Q, Ke F, Zhang W, Shen X, Xu Q, Wang H, Yu XZ, Leng Q (2011) Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice. PLoS ONE 6:e16483
102. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271-2279 (Pubitemid 44498362)
103. Lieberman LA, Cardillo F, Owyang AM, Rennick DM, Cua DJ, Kastelein RA, Hunter CA (2004) IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J Immunol 173:1887-1893 (Pubitemid 38971623)
104. Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J, Guglani L, Alcorn JF, Strawbridge H, Park SM, Onishi R, Nyugen N, Walter MJ, Pociask D, Randall TD, Gaffen SL, Iwakura Y, Kolls JK, Khader SA (2009) Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31:799-810
105. Liu J, Lin F, Strainic MG, An F, Miller RH, Altuntas CZ, Heeger PS, Tuohy VK, Medof ME (2008) IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J Immunol 180:5882-5889
106. Liu W, Ouyang X, Yang J, Liu J, Li Q, Gu Y, Fukata M, Lin T, He JC, Abreu M, Unkeless JC, Mayer L, Xiong H (2009) AP-1 activated by toll-like receptors regulates expression of IL-23 p19. J Biol Chem 284:24006-24016
107. Lloyd A (1996) HIV infection and AIDS. P N G Med J 39:174-180 (Pubitemid 126820309)
108. Lochner M, Peduto L, Cherrier M, Sawa S, Langa F, Varona R, Riethmacher D, Si-Tahar M, Di Santo JP, Eberl G (2008) In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med 205:1381-1393 (Pubitemid 351831494)
109. Louis S, Dutertre C-A, Vimeux L, Fery L, Henno L, Diocou S, Kahi S, Deveau C, Meyer L, Goujard C, Hosmalin A (2010) IL-23 and IL-12p70 production by monocytes and dendritic cells in primary HIV-1 infection. J Leukoc Biol:jlb.1009684
110. Macal M, Sankaran S, Chun TW, Reay E, Flamm J, Prindiville TJ, Dandekar S (2008) Effective CD4+ T-cell restoration in gutassociated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol 1:475-488
111. Mamidi A, DeSimone JA, Pomerantz RJ (2002) Central nervous system infections in individuals with HIV-1 infection. J Neuro-Virol 8:158-167 (Pubitemid 34732698)
112. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT (2006) Transforming growth factor-beta induces development of the T (H)17 lineage. Nature 441:231-234
113. Markel G, Bar-Haim E, Zahavy E, Cohen H, Cohen O, Shafferman A, Velan B (2010) The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis. PLoS ONE 5:e11176
114. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31:321-330
115. McGeachy MJ, Chen Y, Tato CM, Laurence A, Joyce-Shaikh B, Blumenschein WM, McClanahan TK, O'Shea JJ, Cua DJ (2009) The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 10:314-324
116. McGovern D, Powrie F (2007) The IL23 axis plays a key role in the pathogenesis of IBD. Gut 56:1333-1336 (Pubitemid 47517817)
117. Meeks KD, Sieve AN, Kolls JK, Ghilardi N, Berg RE (2009) IL-23 is required for protection against systemic infection with Listeria monocytogenes. J Immunol 183:8026-8034
118. Moens E, Brouwer M, Dimova T, Goldman M, Willems F, Vermijlen D (2011) IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17. J Leukoc Biol 89:743-752
119. Mohan H, Bal A, Garg S, Dalal U (2007) Cytomegalovirus-associated pseudotumor simulating gastric malignancy in acquired immunodeficiency syndrome: a case report with review of literature. Jpn J Infect Dis 60:134-136 (Pubitemid 47009533)
120. Morar N, Willis-Owen SA, Maurer T, Bunker CB (2010) HIVassociated psoriasis: pathogenesis, clinical features, and management. Lancet Infect Dis 10:470-478
121. Munoz M et al (2009) Interleukin (IL)-23 mediates Toxoplasma gondiiinduced immunopathology in the gut via matrixmetalloproteinase- 2 and IL-22 but independent of IL-17. J Exp Med 206:3047-3059
122. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951-1957 (Pubitemid 38032126)
123. Murray HW (1997) Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. J Infect Dis 175:1477-1479 (Pubitemid 27225053)
124. Nakae S, Komiyama Y, Nambu A, Sudo K, IwaseM, Homma I, Sekikawa K, Asano M, Iwakura Y (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375-387 (Pubitemid 35279557)
125. Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci USA 100:5986-5990 (Pubitemid 36576918)
126. Namazi MR (2004) Paradoxical exacerbation of psoriasis in AIDS: proposed explanations including the potential roles of substance P and gram-negative bacteria. Autoimmunity 37:67-71 (Pubitemid 38185912)
127. Ness-Schwickerath KJ, Jin C, Morita CT (2010) Cytokine requirements for the differentiation and expansion of IL-17A- and IL- 22-producing human Vγ2Vδ T Cells. J Immunol 184:7268-7280
128. Newton HB (1995) Common neurologic complications of HIV-1 infection and AIDS. Am Fam Physician 51:387-398
129. Nilsson J, Boasso A, Velilla PA, Zhang R, Vaccari M, Franchini G, Shearer GM, Andersson J, Chougnet C (2006) HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108:3808-3817 (Pubitemid 44864563)
130. Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101:2620-2627 (Pubitemid 36857622)
131. Onlamoon N, Pattanapanyasat K, Ansari AA (2005) Human and nonhuman primate lentiviral infection and autoimmunity. Ann N Y Acad Sci 1050:397-409 (Pubitemid 41129459)
132. Oppmann B et al (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-725
133. Osorio F, LeibundGut-Landmann S, Lochner M, Lahl K, Sparwasser T, Eberl G, Reis e Sousa C (2008) DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 38:3274-3281
134. Parham C et al (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168:5699-5708 (Pubitemid 34556153)
135. Pedroso DC, Tellechea A, Moura L, Fidalgo-Carvalho I, Duarte J, Carvalho E, Ferreira L (2011) Improved survival, vascular differentiation and wound healing potential of stem cells cocultured with endothelial cells. PLoS ONE 6:e16114
136. Pirhonen J, Matikainen S, Julkunen I (2002) Regulation of virusinduced IL-12 and IL-23 expression in human macrophages. J Immunol 169:5673-5678 (Pubitemid 35291668)
137. Piskin G, Sylva-Steenland RM, Bos JD, Teunissen MB (2006) In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol 176:1908-1915 (Pubitemid 43134336)
138. Prendergast A, Prado JG, Kang YH, Chen F, Riddell LA, Luzzi G, Goulder P, Klenerman P (2010) HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS 24:491-502
139. Price R, Brew B, Sidtis J, Rosenblum M, Scheck A, Cleary P (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-592 (Pubitemid 18066218)
140. Quesniaux VJ, Nicolle DM, Torres D, Kremer L, Guerardel Y, Nigou J, Puzo G, Erard F, Ryffel B (2004) Toll-like receptor 2 (TLR2)- dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 172:4425-4434 (Pubitemid 38375258)
141. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, Caccamo M, Oukka M, Weiner HL (2008) Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453:65-71 (Pubitemid 351630328)
142. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, Winter SE, Godinez I, Sankaran S, Paixao TA, Gordon MA, Kolls JK, Dandekar S, Baumler AJ (2008) Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14:421-428 (Pubitemid 351499394)
143. Re F, Strominger JL (2001) Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 276:37692-37699
144. Riol-Blanco L, Lazarevic V, Awasthi A, Mitsdoerffer M, Wilson BS, Croxford A, Waisman A, Kuchroo VK, Glimcher LH, Oukka M (2010) IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. J Immunol 184:1710-1720
145. Sadagopal S, Lorey SL, Barnett L, Basham R, Lebo L, Erdem H, Haman K, Avison M, Waddell K, Haas DW, Kalams SA (2008) Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects. J Virol 82:10418-10428 (Pubitemid 352691154)
146. Sato K, Miyoshi F, Yokota K, Araki Y, Asanuma Y, Akiyama Y, Yoh K, Takahashi S, Aburatani H, Mimura T (2011) Marked induction of c-Maf potein during Th17 cell differentiation and its implication in memory Th cell development. J Biol Chem 286:14963-14971
147. Schnittman SM, Fox L (1997) Preliminary evidence for partial restoration of immune function in HIV type 1 infection with potent antiretroviral therapies: clues from the Fourth Conference on Retroviruses and Opportunistic Diseases. AIDS Res Hum Retrovir 13:815-818 (Pubitemid 27265657)
148. Schulz SM, Kohler G, Schutze N, Knauer J, Straubinger RK, Chackerian AA, Witte E, Wolk K, Sabat R, Iwakura Y, Holscher C, Muller U, Kastelein RA, Alber G (2008a) Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23- dependent IL-22, but not IL-17. J Immunol 181:7891-7901
149. Schulz SM, Köhler G, Schütze N, Knauer J, Straubinger RK, Chackerian AA, Witte E, Wolk K, Sabat R, Iwakura Y, Holscher C, Müller U, Kastelein RA, Alber G (2008b) Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J Immunol 181:7891-7901
150. Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH (2008) Repeated subcutaneous injections of IL12/ 23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 7:796-804
151. Segal LN, Methe BA, Nolan A, Hoshino Y, Rom WN, Dawson R, Bateman E, Weiden MD (2011) HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc Am Thorac Soc 8:282-287
152. Sender LY, Gibbert K, Suezer Y, Radeke HH, Kalinke U, Waibler Z (2010) CD40 ligand-triggered human dendritic cells mount interleukin-23 responses that are further enhanced by danger signals. Mol Immunol 47:1255-1261
153. Sheikh SZ, Matsuoka K, Kobayashi T, Li F, Rubinas T, Plevy SE (2010) Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis. J Immunol 184:4069-4073
154. Sheikh SZ, Kobayashi T, Matsuoka K, Onyiah JC, Plevy SE (2011) Characterization of an interferon-stimulated response element (ISRE) in the Il23a promoter. J Biol Chem 286:1174-1180
155. Shieh TM, Carter DL, Blosser RL, Mankowski JL, Zink MC, Clements JE (2001) Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J NeuroVirol 7:11-24 (Pubitemid 32904354)
156. Shime H, Yabu M, Akazawa T, Kodama K, Matsumoto M, Seya T, Inoue N (2008) Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J Immunol 180:7175-7183
157. Siegemund S, Schutze N, Freudenberg MA, Lutz MB, Straubinger RK, Alber G (2007) Production of IL-12, IL-23 and IL-27p28 by bone marrow-derived conventional dendritic cells rather than macrophages after LPS/TLR4-dependent induction by Salmonella Enteritidis. Immunobiology 212:739-750 (Pubitemid 350246257)
158. Sieve AN, Meeks KD, Lee S, Berg RE (2010) A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFNgamma production. Eur J Immunol 40:2236-2247
159. Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, Klein D, Quesenberry CP Jr, Towner WJ, Abrams DI (2009) HIV infection and the risk of cancers with and without a known infectious cause. AIDS 23:2337-2345
160. Simmons CP, Goncalves NS, Ghaem-Maghami M, Bajaj-Elliott M, Clare S, Neves B, Frankel G, Dougan G, MacDonald TT (2002) Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma. J Immunol 168:1804-1812 (Pubitemid 34135780)
161. Smith E, Zarbock A, Stark MA, Burcin TL, Bruce AC, Foley P, Ley K (2007) IL-23 is required for neutrophil homeostasis in normal and neutrophilic mice. J Immunol 179:8274-8279
162. Smith RL, Warren RB, Eyre S, Ho P, Ke X, Young HS, Griffiths CE, Worthington J (2008) Polymorphisms in the IL-12beta and IL- 23R genes are associated with psoriasis of early onset in a UK cohort. J Investig Dermatol 128:1325-1327 (Pubitemid 351543190)
163. Smits HH, van Beelen AJ, Hessle C, Westland R, de Jong E, Soeteman E, Wold A, Wierenga EA, Kapsenberg ML (2004) Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur J Immunol 34:1371-1380 (Pubitemid 39256016)
164. Sonnenberg GF, Fouser LA, Artis D (2011) Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12:383-390
165. Sonobe Y, Yawata I, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A (2005) Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res 1040:202-207 (Pubitemid 40459635)
166. Spencer DC, Price RW (1992) Human immunodeficiency virus and the central nervous system. Annu Rev Microbiol 46:655-693
167. Spits H, Di Santo JP (2011) The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 12:21-27
168. Stanley H, Fluetsch-Bloom M, Bunce-Clyma M (1991) HIV-related non-Hodgkin's lymphoma. Oncol Nurs Forum 18:875-880
169. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31:331-341
170. Takahashi H, Numasaki M, Lotze MT, Sasaki H (2005) Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunol Lett 98:189-193 (Pubitemid 40602629)
171. Takaku T, Calado RT, Kajigaya S, Young NS (2009) Interleukin-23 receptor (IL-23R) gene polymorphisms in acquired aplastic anemia. Ann Hematol 88:653-657
172. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, Littman DR, O'Shea JJ (2009) Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206:35-41
173. Tato CM, Cua DJ (2008) Reconciling id, ego, and superego within interleukin-23. Immunol Rev 226:103-111
174. Tchatalbachev S, Ghai R, Hossain H, Chakraborty T (2010) Grampositive pathogenic bacteria induce a common early response in human monocytes. BMC Microbiol 10:275
175. Teng MW, Andrews DM, McLaughlin N, von Scheidt B, Ngiow SF, Moller A, Hill GR, Iwakura Y, Oft M, Smyth MJ (2010) IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis. Proc Natl Acad Sci USA 107:8328-8333
176. Thakker P, Leach MW, Kuang W, Benoit SE, Leonard JP, Marusic S (2007) IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J Immunol 178:2589-2598 (Pubitemid 46233462)
177. Town T, Bai F,Wang T, Kaplan AT, Qian F, Montgomery RR, Anderson JF, Flavell RA, Fikrig E (2009) Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 30:242-253
178. Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, Stepankova R, Robinson N, Buonocore S, Tlaskalova-Hogenova H, Cua DJ, Powrie F (2006) Differential activity of IL-12 and IL- 23 in mucosal and systemic innate immune pathology. Immunity 25:309-318
179. Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, Kawakami K, Suda T, Sudo K, Nakae S, Iwakura Y, Matsuzaki G (2007) IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 178:3786-3796 (Pubitemid 46417647)
180. Valmori D, Raffin C, Raimbaud I, Ayyoub M (2010) Human RORgammat+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors. Proc Natl Acad Sci USA 107:19402-19407
181. van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SAJ, Kapsenberg ML, de Jong EC (2007) Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27:660-669 (Pubitemid 47615504)
182. van de Wetering D, de Paus RA, van Dissel JT, van de Vosse E (2009) Salmonella induced IL-23 and IL-1b allow for IL-12 production by monocytes and Mφ1 through induction of IFN-γ in CD56+ NK/NK-like T cells. PLoS ONE 4:e8396
183. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189 (Pubitemid 43214587)
184. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff TH (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 101:4560-4565 (Pubitemid 38437450)
185. von Hertzen L, Joensuu H, Haahtela T (2011) Microbial deprivation, inflammation and cancer. Canc Metastasis Rev 30:211-223
186. Vossenkamper A, Struck D, Alvarado-Esquivel C, Went T, Takeda K, Akira S, Pfeffer K, Alber G, Lochner M, Forster I, Liesenfeld O (2004) Both IL-12 and IL-18 contribute to small intestinal Th1- type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control. Eur J Immunol 34:3197-3207 (Pubitemid 39549398)
187. Wang J, Ma J, Charboneau R, Barke R, Roy S (2011) Morphine inhibits murine dendritic cell interleukin 23 production by modulating TLR2 and Nod2 signaling. J Biol Chem 286(12):10225-32
188. Wei XQ, Rogers H, Lewis MA, Williams DW (2011) The role of the IL-12 cytokine family in directing T-cell responses in oral candidosis. Clin Dev Immunol 2011:697340
189. Wiekowski MT, Leach MW, Evans EW, Sullivan L, Chen SC, Vassileva G, Bazan JF, Gorman DM, Kastelein RA, Narula S, Lira SA (2001) Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J Immunol 166:7563-7570 (Pubitemid 32525637)
190. Wittig BM (2007) Drug evaluation: CNTO-1275, a mAb against IL- 12/IL-23p40 for the potential treatment of inflammatory diseases. Curr Opin Investig Drugs 8:947-954 (Pubitemid 350071261)
191. Wozniak TM, Ryan AA, Britton WJ (2006) Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40- deficient mice and is not required for the development of IL-17- secreting T cell responses. J Immunol 177:8684-8692 (Pubitemid 44893833)
192. Wozniak TM, Saunders BM, Ryan AA, Britton WJ (2010) Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect Immun 78:4187-4194
193. Xu J, Drew PD (2007) Peroxisome proliferator-activated receptorgamma agonists suppress the production of IL-12 family cytokines by activated glia. J Immunol 178:1904-1913 (Pubitemid 46154663)
194. Yadav A, Collman RG (2009) CNS inflammation and macrophage/ microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol 4:430-447
195. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, Ma L, Shah B, Panopoulos AD, Schluns KS, Watowich SS, Tian Q, Jetten AM, Dong C (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28:29-39
196. Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, Summer WR, Schwarzenberger P, Shellito JE, Kolls JK (2001) Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 25:335-340 (Pubitemid 32918915)
197. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, Belladonna ML, Vacca C, Conte C, Mosci P, Bistoni F, Puccetti P, Kastelein RA, Kopf M, Romani L (2007) IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37:2695-2706 (Pubitemid 47578289)
198. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR (2007) IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8:967-974 (Pubitemid 47300011)